Research progress of exogenous application of substance P to promote the healing of chronic diabetic wounds

doi:10.3877/cma.j.issn.1673-9450.2022.02.013

Abstract

Abstract:

Diabetes is a serious disease that is prevalent worldwide and increasing year by year. Diabetic foot ulcer is one of the main complications of diabetes.Substance P (SP) is a neuropeptide which plays an important role in wound healing and immune activity and is famous for its role in sensory nervous system. This article reviews the mechanism of SP promoting chronic wound healing in diabetic environment.

Key words: Diabetes Mellitus, Diabetic foot, Wound healing, Substance P, Chronic wound

Miaomiao Zhang, Xiaoping Yu, Qianqian Fu, Junli Zhou. Research progress of exogenous application of substance P to promote the healing of chronic diabetic wounds[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2022, 17(02): 159-162.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhssyxfzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1673-9450.2022.02.013

https://zhssyxfzz.cma-cmc.com.cn/EN/Y2022/V17/I02/159

References 47

[1]	Sen CK, Gordillo GM, Roy S, et al. Human skin wounds: a major and snowballing threat to public health and the economy[J]. Wound Repair Regen, 2009, 17(6): 763-771.
[2]	Okano J, Kojima H, Katagi M, et al. Hyperglycemia Induces Skin Barrier Dysfunctions with Impairment of Epidermal Integrity in Non-Wounded Skin of Type 1 Diabetic Mice[J]．PLoS One, 2016, 11(11): e0166215.
[3]	Oyibo SO, Jude EB, Tarawneh I, et al. The effects of ulcer size and site, patient′s age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers[J]．Diabet Med, 2001, 18(2): 133-138.
[4]	Jude EB, Oyibo SO, Chalmers N, et al. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome[J]．Diabetes Care, 2001, 24(8): 1433-1437.
[5]	Papini M, Cicoletti M, Fabrizi V, et al. Skin and nail mycoses in patients with diabetic foot[J]．G Ital Dermatol Venereol, 2013, 148(6): 603-608.
[6]	Poradzka A, Jasik M, Karnafel W, et al. Clinical aspects of fungal infections in diabetes[J]．Acta Pol Pharm, 2013, 70(4): 587-596.
[7]	Lasagni Vitar RM, Rama P, Ferrari G. The two-faced effects of nerves and neuropeptides in corneal diseases[J]．Prog Retin Eye Res, 2021, 100974.
[8]	Soniecka M, Le Roux S, Zhou Q, et al. Substance P Enhances Keratocyte Migration and Neutrophil Recruitment through Interleukin-8[J]．Mol Pharmacol, 2016, 89(2): 215-225.
[9]	Mouritzen MV, Abourayale S, Ejaz R, et al. Neurotensin, substance P, and insulin enhance cell migration[J]．J Pept Sci, 2018, 24(7): e3093.
[10]	Kowtharapu BS, Stahnke T, Wree A, et al. Corneal epithelial and neuronal interactions: role in wound healing[J]．Exp Eye Res, 2014, 125: 53-61.
[11]	Ochoa O, Torres FM, Shireman PK. Chemokines and diabetic wound healing[J]．Vascular, 2007, 15(6): 350-355.
[12]	Khanna S, Biswas S, Shang Y, et al. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice[J]．PLoS One, 2010, 5(3): e9539.
[13]	Blais M, Mottier L, Germain MA, et al. Sensory neurons accelerate skin reepithelialization via substance P in an innervated tissue-engineered wound healing model[J]．Tissue Eng Part A, 2014, 20(15/16): 2180-2188.
[14]	Chéret J, Lebonvallet N, Buhé V, et al. Influence of sensory neuropeptides on human cutaneous wound healing process[J]．J Dermatol Sci, 2014, 74(3): 193-203.
[15]	Suvas S. Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis[J]．J Immunol, 2017, 199(5): 1543-1552.
[16]	Muchowska A, Redkiewicz P, Róycki K, et al. The analgesic hybrid of dermorphin/substance P and analog of enkephalin improve wound healing in streptozotocin-induced diabetic rats[J]．Wound Repair Regen, 2020, 28(2): 177-184.
[17]	Mahdavian Delavary B, van der Veer WM, van Egmond M, et al. Macrophages in skin injury and repair[J]．Immunobiology, 2011, 216(7): 753-762.
[18]	Odegaard JI, Chawla A. Mechanisms of macrophage activation in obesity-induced insulin resistance[J]．Nat Clin Pract Endocrinol Metab, 2008, 4(11): 619-626.
[19]	Lim JE, Chung E, Son Y. A neuropeptide, Substance-P, directly induces tissue-repairing M2 like macrophages by activating the PI3K/Akt/mTOR pathway even in the presence of IFNγ[J]．Sci Rep, 2017, 7(1): 9417.
[20]	Martin KE, García AJ. Macrophage phenotypes in tissue repair and the foreign body response: Implications for biomaterial-based regenerative medicine strategies[J]．Acta Biomater, 2021: S1742-7061(21)00188-4.
[21]	Martin A, Komada MR, Sane DC. Abnormal angiogenesis in diabetes mellitus[J]．Med Res Rev, 2003, 23(2): 117-145.
[22]	Brem H, Jacobs T, Vileikyte L, et al. Wound-healing protocols for diabetic foot and pressure ulcers[J]．Surg Technol Int, 2003, 11: 85-92.
[23]	Ding WG, Zhang ZM, Zhang YH, et al. Changes of substance P during fracture healing in ovariectomized mice[J]．Regul Pept, 2010, 159(1/3): 28-34.
[24]	Kumar S, Tan Y, Berthiaume F. Neuropeptide Substance P Enhances Skin Wound Healing In Vitro and In Vivo under Hypoxia[J]．Biomedicines, 2021, 9(2): 222.
[25]	Kant V, Kumar D, Kumar D, et al. Topical application of substance P promotes wound healing in streptozotocin-induced diabetic rats[J]．Cytokine, 2015, 73(1): 144-155.
[26]	Li M, Hou Q, Zhong L, et al. Macrophage Related Chronic Inflammation in Non-Healing Wounds[J]．Front Immunol, 2021, 12: 681710.
[27]	Kant V, Gopal A, Kumar D, et al. Topically applied substance P enhanced healing of open excision wound in rats[J]．Eur J Pharmacol, 2013, 715(1/3): 345-353.
[28]	Fadini GP, Miorin M, Facco M, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus[J]．J Am Coll Cardiol, 2005, 45(9): 1449-1457.
[29]	Um J, Yu J, Park KS. Substance P accelerates wound healing in type 2 diabetic mice through endothelial progenitor cell mobilization and Yes-associated protein activation[J]．Mol Med Rep, 2017, 15(5): 3035-3040.
[30]	Velazquez OC. Angiogenesis and vasculogenesis: inducing the growth of new blood vessels and wound healing by stimulation of bone marrow-derived progenitor cell mobilization and homing[J]．J Vasc Surg, 2007, 45 Suppl A(Suppl A): A39-A47.
[31]	Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration[J]．Nat Med, 2003, 9(6): 702-712.
[32]	Amadesi S, Reni C, Katare R, et al. Role for substance p-based nociceptive signaling in progenitor cell activation and angiogenesis during ischemia in mice and in human subjects[J]．Circulation, 2012, 125(14): 1774-1786, S1-S19.
[33]	Um J, Jung N, Chin S，et al. Substance P enhances EPC mobilization for accelerated wound healing[J]．Wound Repair Regen, 2016, 24(2): 402-410.
[34]	Jung N, Yu J, Um J, et al. Substance P modulates properties of normal and diabetic dermal fibroblasts[J]．Tissue Eng Regen Med, 2016, 13(2): 155-161.
[35]	Han SK, Choi KJ, Kim WK. Clinical application of fresh fibroblast allografts for the treatment of diabetic foot ulcers: a pilot study[J]．Plast Reconstr Surg, 2004, 114(7): 1783-1789.
[36]	Monami M, Vivarelli M, Desideri CM, et al. Autologous skin fibroblast and keratinocyte grafts in the treatment of chronic foot ulcers in aging type 2 diabetic patients[J]．J Am Podiatr Med Assoc, 2011, 101(1): 55-58.
[37]	Khan M, Akhtar S, Mohsin S, et al. Growth factor preconditioning increases the function of diabetes-impaired mesenchymal stem cells[J]．Stem Cells Dev, 2011, 20(1): 67-75.
[38]	Jin P, Zhang X, Wu Y, et al. Streptozotocin-induced diabetic rat-derived bone marrow mesenchymal stem cells have impaired abilities in proliferation, paracrine, antiapoptosis, and myogenic differentiation[J]．Transplant Proc, 2010, 42(7): 2745-2752.
[39]	Crisan M, Corselli M, Chen WC, et al. Perivascular cells for regenerative medicine[J]．J Cell Mol Med, 2012, 16(12): 2851-2860.
[40]	Kang MH, Kim DY, Yi JY, et al. Substance P accelerates intestinal tissue regeneration after gamma-irradiation-induced damage[J]．Wound Repair Regen, 2009, 17(2): 216-223.
[41]	Kim JH, Jung Y, Kim BS, et al. Stem cell recruitment and angiogenesis of neuropeptide substance P coupled with self-assembling peptide nanofiber in a mouse hind limb ischemia model[J]．Biomaterials, 2013, 34(6): 1657-1668.
[42]	Ennis WJ, Sui A, Bartholomew A. Stem Cells and Healing: Impact on Inflammation[J]．Adv Wound Care (New Rochelle), 2013, 2(7): 369-378.
[43]	Jin Y, Hong HS, Son Y. Substance P enhances mesenchymal stem cells-mediated immune modulation[J]．Cytokine, 2015, 71(2): 145-153.
[44]	Lepperdinger G. Inflammation and mesenchymal stem cell aging[J]．Curr Opin Immunol, 2011, 23(4): 518-524.
[45]	Yang L, Di G, Qi X, et al. Substance P promotes diabetic corneal epithelial wound healing through molecular mechanisms mediated via the neurokinin-1 receptor[J]．Diabetes, 2014, 63(12): 4262-4274.
[46]	Koh YH, Moochhala S, Bhatia M. The role of neutral endopeptidase in caerulein-induced acute pancreatitis[J]．J Immunol, 2011, 187(10): 5429-5439.
[47]	Felderbauer P, Bulut K, Hoeck K, et al. Substance P induces intestinal wound healing via fibroblasts--evidence for a TGF-beta-dependent effect[J]．Int J Colorectal Dis, 2007, 22(12):1475-1480.

Please choose a citation manager

Content to export